{
  "kind": "framework",
  "value": "pyramid-principle",
  "collectionKey": "slides:framework:pyramid-principle:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 1,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de076-4b6e-745e-b621-2097373bdc12",
      "docSlug": "454a033dcd11e0912fc4b281c3c86d65",
      "documentTitle": "Innoviva | Results Presentation Deck | 7 slides",
      "authorId": "innoviva",
      "authorName": "Innoviva",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "Headline doubles as action title with a positive-result takeaway; body is a pure bulleted summary with footnoted Lancet citations and Innoviva branding bottom-right.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "Action-title headline states the conclusion ('positive Phase 3 results'); supporting bullets elaborate the underlying evidence.",
      "slideHref": "/slides/019de076-4b6e-745e-b621-2097373bdc12/2",
      "deckHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12",
      "deckAnchorHref": "/decks/019de076-4b6e-745e-b621-2097373bdc12#slide-2",
      "loopMatches": [
        {
          "to": 7,
          "from": 2,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "cc60ccb3-7bfb-482b-bd2f-71df33588aa9",
          "evidence": "Implication of antibiotic resistance and need for new treatments",
          "position": 0,
          "objective": "What are the consequences of not adopting Zoliflodacin?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 2,
          "from": 2,
          "beatId": "2dd973bd-2205-4a64-8b7e-91aa8f1ca8cd",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Need",
          "beatSlug": "monroes-sequence-need",
          "evidence": "Positive topline summary",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}